CORDIS · 101125695 · HORIZON

ActSwiftly Activation and switch of fates in T lymphocytes.

Coordinator: USTAV MOLEKULARNI GENETIKY AV CR V.V.I. (CZ)

Antigen-stimulated naïve CD8+ T cells proliferate and differentiate into effector and memory cells. Whereas effector T cells remove infected or cancerous cells, memory T cells protect the organism from re-infections. Despite decades of research, the challenging central questions of how naïve T cells form diverse progeny and what drives the differential response of naïve and memory T cells to infection remain unanswered, largely because of lacking experimental tools.The goal of this project is to generate a comprehensive model of cell-fate choices of naïve and memory CD8+ T cells in vivo. We w…

EU contribution
€2.6M
Total cost
€2.6M
Period
2025-01-01 → 2029-12-31
Framework
Horizon Europe (2021–2027)
Funding scheme
HORIZON-ERC
Call
ERC-2023-COG
Status
SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

EU contribution: €2.6M awarded to the consortium. The project runs over approximately 5 years from 2025-01-01 to 2029-12-31.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-ERC funding scheme.
What is the EU contribution?
The European Commission contributes €2.6M toward a total project budget of €2.6M.
Which EU programme funds it?
The project is funded under Horizon Europe (2021–2027), call ERC-2023-COG.
Who coordinates the project?
The project is coordinated by USTAV MOLEKULARNI GENETIKY AV CR V.V.I. (CZ).
What is the project timeline?
The project runs from 2025-01-01 to 2029-12-31 — approximately 5 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101125695.